Skip to main content
OpenTrials

Clinical trial condition

Diffuse Large B-cell Lymphoma

Explore clinical trials studying Diffuse Large B-cell Lymphoma. Study availability and eligibility vary by location and protocol.

213 public trials 54 recruiting studies
Refine in advanced search Browse all conditions

Diffuse Large B-cell Lymphoma trial results

Completed

Ibrutinib in Patients With Refractory/Relapsed Non-GCB Diffuse Large B-cell Lymphoma Non-candidates to ASCT

NCT02692248

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Hospital Universitario Son Espases Palma, Balearic Islands, Spain
  • Hospital Especialidades Jerez de la Frontera, Cádiz, Spain
  • Hospital Universitario Donostia Donostia / San Sebastian, Guipúzcoa, Spain
  • Hospital de Navarra Pamplona, Navarre, Spain
View all 17 locations
View Trial Details
Completed

Blood Sample Markers of Reproductive Hormones in Assessing Ovarian Reserve in Younger Patients With Newly Diagnosed Lymphomas

NCT01793233

Conditions
Anaplastic Large Cell Lymphoma, Burkitt Lymphoma, DNA Virus Infections, +21 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Kaiser Permanente Downey Medical Center Downey, California, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
View all 107 locations
View Trial Details
Completed

Study to Evaluate the Efficacy and Tolerability of Debio 1562 in Combination With Rituximab in Participants With Relapsed and/or Refractory DLBCL and Other Forms of NHL

NCT02564744

Conditions
B-cell Non-Hodgkin's Lymphoma, Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, +10 more
Locations
  • Alabama Oncology Birmingham, Alabama, United States
  • Carle Foundation Hospital, Cancer Center Urbana, Illinois, United States
  • Abbott Northwestern Hospital, Virginia Piper Cancer Institute Minneapolis, Minnesota, United States
  • Novant Health Oncology Winston-Salem, North Carolina, United States
View all 39 locations
View Trial Details
Completed

A Study of Zilovertamab Vedotin (MK-2140) (VLS-101) in Participants With Hematologic Malignancies (MK-2140-001)

NCT03833180

Conditions
Acute Lymphoid Leukemia, Acute Myeloid Leukemia, Blood Protein Disorders, +49 more
Locations
  • City of Hope ( Site 0010) Duarte, California, United States
  • University of California - San Diego ( Site 0003) La Jolla, California, United States
  • UCLA Hematology & Oncology ( Site 0007) Los Angeles, California, United States
  • University of Nebraska Medical Center ( Site 0006) Omaha, Nebraska, United States
View all 14 locations
View Trial Details

Related conditions